Infections Clinical Trials in Edmonton, Alberta
7 recruitingEdmonton, Alberta, Canada
Showing 1–7 of 7 trials
Recruiting
Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection RecurrenceClostridium DifficileClostridioides Difficile Infection+7 more
Vedanta Biosciences, Inc.852 enrolled215 locationsNCT06237452
Recruiting
Phase 3
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Invasive Mold Infections
Basilea Pharmaceutica234 enrolled49 locationsNCT06925321
Recruiting
Phase 2
Antibiotic Prophylaxis for Neurogenic Bladder Botox
Neurogenic BladderPost-operative Urinary Tract Infections
University of Alberta160 enrolled1 locationNCT04791579
Recruiting
Breakthrough CMV Lung Transplant -Multicentre
Cytomegalovirus Infections
University of Alberta40 enrolled1 locationNCT04439916
Recruiting
Phase 2
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
Respiratory Syncytial Virus Infections
GlaxoSmithKline184 enrolled37 locationsNCT07092865
Recruiting
Not Applicable
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada
InfectionsSurgical Site InfectionsSurgical Wound Infections+1 more
Ondine Biomedical Inc.4,740 enrolled4 locationsNCT07189858
Recruiting
Phase 2
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
InfectionsAcute Respiratory Distress Syndrome
BioAegis Therapeutics Inc.600 enrolled76 locationsNCT05947955